Based on our killing measurements using target cell lines expressing different Fn14 levels, we conclude that the RevCAR system response is TAA dependent and requires a certain TAA threshold which might be beneficial for their discrimination between TAAlow-expressing normal cells and TAAhigh-expressing tumor cells and, consequently, might reduce off-target toxicities. The gene discussed is TNFRSF12A; the disease is neoplasm.